Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
67 studies found for:    "Pilocytic astrocytoma"
Show Display Options
Rank Status Study
21 Completed Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide;   Genetic: protein expression analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: diagnostic laboratory biomarker analysis;   Other: immunoenzyme technique
22 Withdrawn Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Procedure: conventional surgery;   Procedure: magnetic resonance imaging;   Procedure: magnetic resonance spectroscopic imaging
23 Recruiting Bevacizumab in Recurrent Grade II and III Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Biological: Bevacizumab;   Drug: Temozolomide
24 Recruiting Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Conditions: Brain and Central Nervous System Tumors;   Intraocular Melanoma;   Lung Cancer;   Melanoma (Skin);   Metastatic Cancer;   Neuroblastoma;   Ovarian Cancer;   Retinoblastoma;   Sarcoma;   Small Intestine Cancer
Interventions: Genetic: DNA analysis;   Other: immunologic technique;   Other: pharmacological study;   Radiation: iodine I 131 monoclonal antibody 3F8;   Radiation: 131I-3F8
25 Completed Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors
Conditions: Adrenocortical Carcinoma;   Brain and Central Nervous System Tumors;   Head and Neck Cancer;   Liver Cancer;   Malignant Mesothelioma;   Pheochromocytoma;   Sarcoma
Interventions: Drug: cisplatin;   Drug: doxorubicin hydrochloride;   Drug: tamoxifen citrate;   Procedure: conventional surgery;   Radiation: radiation therapy
26 Active, not recruiting Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: lomustine;   Drug: procarbazine hydrochloride;   Drug: vincristine sulfate;   Radiation: radiation therapy
27 Completed Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: gefitinib
28 Completed Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer
Conditions: Brain and Central Nervous System Tumors;   Breast Cancer;   Gastrointestinal Carcinoid Tumor;   Islet Cell Tumor;   Lung Cancer;   Lymphoma;   Melanoma (Skin);   Neoplastic Syndrome
Intervention: Radiation: yttrium Y 90-edotreotide
29 Completed Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas
Conditions: Brain and Central Nervous System Tumors;   Breast Cancer;   Kidney Cancer;   Lung Cancer;   Lymphoma;   Melanoma (Skin);   Ovarian Cancer;   Small Intestine Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: carboxyamidotriazole;   Drug: paclitaxel
30 Completed Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other Cancers
Condition: Stage IV Melanoma
Interventions: Biological: recombinant interferon alfa-2b;   Drug: cisplatin;   Drug: sodium stibogluconate;   Drug: dacarbazine;   Drug: vinblastine
31 Completed MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma
Condition: Cancer
Intervention: Drug: entinostat
32 Completed BCX-1777 in Treating Patients With Refractory Cancer
Condition: Cancer
Intervention: Drug: forodesine hydrochloride
33 Completed Temozolomide in Treating Patients With Progressive Low-Grade Glioma
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: temozolomide
34 Active, not recruiting Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: lonafarnib;   Drug: temozolomide
35 Completed Thalidomide and Docetaxel in Treating Patients With Advanced Cancer
Condition: Cancer
Interventions: Drug: docetaxel;   Drug: thalidomide
36 Completed Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: imatinib mesylate;   Other: pharmacological study;   Procedure: conventional surgery
37 Completed Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors
Conditions: Brain and Central Nervous System Tumors;   Chemotherapeutic Agent Toxicity;   Infertility
Intervention:
38 Terminated Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors
Conditions: Brain and Central Nervous System Tumors;   Cognitive/Functional Effects;   Depression;   Fatigue;   Quality of Life
Interventions: Drug: methylphenidate hydrochloride;   Procedure: quality-of-life assessment;   Radiation: radiation therapy
39 Completed Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors
Conditions: Brain and Central Nervous System Tumors;   Metastatic Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: carboplatin;   Drug: tamoxifen citrate;   Drug: topotecan hydrochloride;   Other: pharmacological study
40 Recruiting Temozolomide in Treating Patients With Low-Grade Glioma
Condition: CNS Tumor, Adult
Intervention: Drug: temozolomide

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years